default author photo

Vinodh Edward

Aurum Institute

SCHOLARLY PAPERS

3

DOWNLOADS

321

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Randomised Trial of a Single Dose of Ad26.COV2.S, BNT162b2 or SARS-CoV-2-rS-PN in Previously Vaccinated and Unvaccinated Adults Living with and without HIV in South Africa: Safety and Immunogenicity

Number of pages: 21 Posted: 14 May 2025
Aurum Institute, South African Medical Research Council - Biostatistics Research Unit, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Chris Hani Baragwanath Academic Hospital - Perinatal HIV Research Unit, Aurum Institute, The Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, Aurum Institute, National Health Laboratory Services (NHLS) - National Institute for Communicable Diseases, University of the Witwatersrand, University of Cape Town (UCT) - Institute of Infectious Disease and Molecular Medicine, University of Cape Town (UCT) - Institute of Infectious Disease and Molecular Medicine, Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Government of India - Translational Health Science & Technology Institute (THSTI), Aurum Institute, South African Medical Research Council, South African Medical Research Council, Aurum Institute, Aurum Institute, Aurum Institute and Independent
Downloads 135 (540,814)

Abstract:

Loading...

randomised controlled trial, clinical trial, people living with HIV, COVID-19 vaccines, booster vaccines

2.

Simultaneous Initiation of Dolutegravir-Based Antiretroviral Treatment and Once-Weekly Rifapentine and Isoniazid (3HP) for Tuberculosis Prevention in Antiretroviral-Naïve People with HIV: A Phase 1/2 Trial

Number of pages: 22 Posted: 12 Sep 2024
Johns Hopkins University - Division of Clinical Pharmacology, Aurum Institute, Aurum Institute, Aurum Institute, Johns Hopkins University, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Johns Hopkins University - Bloomberg School of Public Health, University of Cape Town (UCT), Aurum Institute, Aurum Institute, Aurum Institute, University of California, San Francisco (UCSF) - Department of Bioengineering and Therapeutic Sciences, Vanderbilt University - Medical Center, Johns Hopkins University, Aurum Institute, Independent and Independent
Downloads 130 (558,171)

Abstract:

Loading...

Tuberculosis, TB Preventive Treatment, HIV/AIDS, Drug-Drug Interaction Study

3.

Incidence of Herpes Simplex Virus Type 2 Infection Among African Women Using Depot Medroxyprogesterone Acetate, a Copper Intrauterine Device, or a Levonorgestrel Implant for Contraception: A Nested Randomized Trial

Number of pages: 39 Posted: 11 Jun 2021
University of Washington - Department of Global Health, University of Washington - Department of Global Health, University of Washington - Department of Global Health, University of the Witwatersrand - Reproductive Health and HIV Research Unit (RHRU), University of Washington - Department of Global Health, FHI 360, Government of the United States of America - Division of HIV Prevention, Kenya Medical Research Institute (KEMRI) - Center for Clinical Research, University of the Witwatersrand - MatCH Research Unit (MRU), Columbia University - ICAP, University of the Witwatersrand - MatCH Research Unit (MRU), Kenya Medical Research Institute (KEMRI) - Center for Clinical Research, Aurum Institute, Fred Hutchinson Cancer Research Center and University of Washington - Department of Global Health
Downloads 56 (1,000,027)

Abstract:

Loading...

Herpes simplex virus type 2 (HSV-2), HIV, contraception, women, Africa